New pill takes aim at Hard-to-Treat breast cancers
NCT ID NCT07408089
First seen Feb 15, 2026 · Last updated May 24, 2026 · Updated 12 times
Summary
This early-phase study tests an experimental oral drug called BBI-940 in people with advanced or metastatic breast cancer. The drug works by breaking down a protein that cancer cells need to grow. The study will find the safest dose and see if it works alone or with another drug. About 96 adults with certain types of breast cancer that have not responded to standard treatments can join.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
NEXT Oncology
RECRUITINGAustin, Texas, 78758, United States
-
NEXT Oncology
RECRUITINGHouston, Texas, 77054, United States
-
NEXT Oncology
RECRUITINGSan Antonio, Texas, 78229, United States
-
NEXT Oncology
RECRUITINGFairfax, Virginia, 22031, United States
-
The START Center for Cancer Care
RECRUITINGSan Antonio, Texas, 78229, United States
-
The START Center for Cancer Research
RECRUITINGLos Angeles, California, 90025, United States
-
The START Center for Cancer Research
RECRUITINGLake Success, New York, 11042, United States
-
University of Texas Southwestern Medical Center
RECRUITINGDallas, Texas, 75390, United States
Conditions
Explore the condition pages connected to this study.